Royal Canin

Royal Canin scores in the upper tier on Chowmark. Founded in France in 1968 by veterinarian Dr. Jean Cathary, Royal Canin is now owned by Mars Petcare and is one of the most clinically respected pet food brands in the world. Its breed-specific and condition-specific formulas are a genuine differentiator — Royal Canin produces more SKUs tailored to specific breeds, sizes, and health conditions than any other brand in the category.

Royal Canin has recorded zero lifetime recalls with the FDA or CFIA. That is a meaningful safety record for a brand of this scale and distribution.

Royal Canin meets WSAVA Global Nutrition Guidelines. The brand employs board-certified veterinary nutritionists, conducts AAFCO feeding trials, and has an extensive body of peer-reviewed research behind its formulas. The Veterinary Diet line — developed for disease management — is widely used in veterinary practice alongside Hill's Prescription Diet.

The WSAVA conflict-of-interest note: Royal Canin is one of the funding sources for WSAVA's Global Nutrition Committee, alongside Purina Institute and Hill's Pet Nutrition. Chowmark discloses this on its methodology page.

One honest note on ingredient lists: Royal Canin's ingredient panels often look less impressive than competitors at a similar price point — corn, chicken by-product meal, and brewers rice appear frequently. The brand's position is that ingredient quality is less important than nutritional precision and digestibility, and that its formulas are validated by feeding trials and clinical outcomes rather than ingredient aesthetics. That is a defensible position backed by research, but it is a real tension for ingredient-conscious pet owners.

The bottom line: Royal Canin is one of Chowmark's top-tier recommendations for pet owners who want evidence-based, clinically validated nutrition — particularly for breed-specific needs or health management. The ingredient list aesthetics are a secondary consideration given the research foundation.